Related Experiment Video
Updated: Jun 24, 2026

12:50
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
Insights on Endothelial Injury
1School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, Louisiana, USA.
Cell Biochemistry and Function
|June 23, 2026
Summary
This study reviews new drug therapies for severe diseases like sepsis and lung injury. It focuses on treatments targeting endothelial barrier dysfunction, a key feature of these conditions.
Area of Science:
- Biomedical Science
- Pharmacology
- Pathophysiology
Background:
- Endothelial barrier dysfunction is a critical factor in severe diseases such as sepsis and acute lung injury.
- Understanding the mechanisms of endothelial dysfunction is crucial for developing effective treatments.
Purpose of the Study:
- To summarize recent advancements in pharmacotherapies for endothelium-dependent disorders.
- To highlight novel findings in the development of treatments for endothelial barrier dysfunction.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of preclinical and clinical studies on pharmacotherapies.
- Synthesis of current research on endothelial barrier function.
Main Results:
- Identification of emerging drug targets for endothelial dysfunction.
- Overview of promising therapeutic strategies currently under investigation.
- Summary of key findings from recent studies in the field.
Conclusions:
- Pharmacotherapies targeting endothelial barrier dysfunction show significant potential for treating severe diseases.
- Continued research is essential to translate these findings into clinical practice.
- Novel therapeutic approaches are emerging to combat endothelium-dependent disorders.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
